Anette K. S.
- Country
- Norway
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Solid Tumor Oncology
Focuses on the treatment of aggressive bladder cancer, advanced clear cell renal carcinoma, metastatic prostate cancer, and high‑risk melanoma following surgical resection.
- Targeted therapy combinations for urothelial carcinoma
- Neoadjuvant immunotherapy in muscle‑invasive bladder cancer
- Precision medicine approaches for rare renal tumors
- Adjuvant checkpoint inhibition in resected melanoma
- Hormone‑resistant prostate cancer treatment strategies
Contributes to expanding therapeutic options for patients with limited curative alternatives.
Hematologic Malignancies & Immune Cytopenias
Specializes in diseases such as multiple myeloma, diffuse large B‑cell lymphoma, and chronic immune thrombocytopenia, integrating novel agents with standard regimens.
- Combination regimens for relapsed multiple myeloma
- BTK inhibition in refractory immune thrombocytopenia
- CAR‑T cell therapy evaluation in aggressive B‑cell lymphoma
- Biomarker‑driven treatment selection for plasma cell disorders
- Safety profiling of novel immunomodulators in cytopenic states
Advances therapeutic landscapes for blood‑derived cancers and autoimmune cytopenias.
Metabolic & Cardiovascular Therapeutics
Addresses metabolic liver disease (non‑alcoholic steatohepatitis) and cardiovascular risk factors including type 2 diabetes, hypertension, and atherosclerotic disease in renal failure.
- Antifibrotic agents for NASH with advanced fibrosis
- SGLT2 inhibitor combinations for diabetes‑related cardiovascular protection
- Iron repletion strategies in heart failure with reduced ejection fraction
- Anticoagulant alternatives for patients with atrial fibrillation at high stroke risk
- Lipid‑lowering therapies for heterozygous familial hypercholesterolaemia
Targets intersecting pathways of metabolic dysfunction and vascular disease.
Infectious Disease & Emerging Pathogens
Investigates therapeutic interventions for viral illnesses such as SARS‑CoV‑2 and monkeypox virus disease, emphasizing antiviral efficacy and safety.
- Oral antiviral regimens for moderate COVID‑19
- Targeted antiviral therapy for orthopoxvirus infections
- Immune modulation in severe respiratory viral infections
- Outpatient management strategies for post‑viral complications
- Evaluation of host‑directed therapies in viral pneumonia
Supports rapid translation of treatments for pandemic‑relevant pathogens.
Neurology & Stroke Management
Concentrates on acute cerebrovascular events, including acute ischemic stroke and central retinal artery occlusion, as well as chronic neurological conditions like chronic migraine.
- Antiplatelet strategies to prevent recurrent ischemic stroke
- Thrombolytic therapy optimization for retinal artery occlusion
- Dual therapy combining CGRP monoclonal antibodies with onabotulinumtoxin A for migraine
- Biomarker‑guided de‑escalation of antithrombotic therapy post‑stroke
- Neuroprotective adjuncts in the early window after stroke onset
Enhances acute and preventive care pathways for cerebrovascular and headache disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.